[APLS] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[APLS] Apellis Pharmaceuticals, Inc.
Announcement Date
20-Dec-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 4.56%
YoY- -60.49%
Quarter Report
APLS's Result
APLS's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 646 0 0 0 0 0 0 -
PBT -135,700 -69,825 -35,972 -11,573 -7,211 -31,632 -2,662 92.44%
Tax 9,483 540 -281 -11,589 -7,234 -442 -192 -
NP -135,700 -69,825 -35,972 -11,573 -7,211 -31,189 -2,470 94.85%
Tax Rate - - - - - - - -
Total Cost 136,346 69,825 35,972 11,573 7,211 31,189 2,470 95.01%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -21,006.19 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -1.79 -1.10 -0.64 -0.30 -0.40 -1.72 -0.14 52.85%
EPS Diluted -1.79 -1.10 -0.64 -0.30 -0.40 -1.72 -0.14 52.85%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.